News Daily News Women Less Likely Than Men to Adhere to Post-ACS Medications: TEXTMEDS Michael O'Riordan April 13, 2026
News Daily News CTO PCI Reduces Symptoms, Improves Quality of Life: Meta-analysis Michael O'Riordan April 09, 2026
News Conference News ACC 2026 Oral PCSK9 Inhibitor Bests Other Nonstatin Therapies for LDL-Lowering Michael O'Riordan April 01, 2026
News Conference News ACC 2026 SMART-DECISION: Stopping Beta-blockers Post-MI Safe in Stable Patients Michael O'Riordan March 30, 2026
Presentation ACC 2026 Essence-TIMI 73b CCTA Trial: Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis Presenter: Nicholas Marston March 30, 2026
News Conference News ACC 2026 PCSK9 Inhibitor Very Effective in High-risk Patients Without ASCVD: VESALIUS-CV Michael O'Riordan March 29, 2026
News Conference News ACC 2026 Very Low LDL Levels Best in Secondary Prevention: Ez-PAVE Yael L. Maxwell March 28, 2026
News Daily News Genomics, Lipids, Inflammation at Midlife Predict Future CAD Caitlin E. Cox March 25, 2026
News Daily News No Major Progress on Making CV Care More Affordable: JACC Stats Todd Neale March 18, 2026
News Daily News Oral Anticoagulation Alone Best for Stable CAD Patients With AF: Meta-analysis Yael L. Maxwell March 12, 2026
News Conference News CRT 2026 Large Variability in Use of Invasive Strategy for Type 1 NSTEMI: NCDR Michael O'Riordan March 11, 2026
News Conference News CRT 2026 DOBERMANN: Dobutamine and Tocilizumab Show Promise in Pre-Shock Patients L.A. McKeown March 09, 2026
News Daily News HBR Common, Impactful Among All-Comer Acute MI Patients Yael L. Maxwell March 05, 2026
News Daily News Healthy Lifestyle Plus GLP-1s Yields Bigger CV Reduction Than Drugs Alone Michael O'Riordan March 03, 2026
News Daily News Side Effects of Statins Might Be Overstated: CTT Collaboration Michael O'Riordan February 12, 2026
Presentation Controversies and Advances 2026 We are Overtreating Patients with PCI: Ischemia is More Complicated Than What You Can Fix in the Lab Presenter: Rasha Al-Lamee February 06, 2026
Presentation Controversies and Advances 2026 Severe AS Plus Severe CAD: Controversies and Future Directions Presenter: George Dangas February 06, 2026
Presentation Controversies and Advances 2026 The Latest on Pharmacotherapy for CAD: What Everyone Needs to Know Presenter: Roxana Mehran February 06, 2026